IMAX Co. Expected to Post FY2025 Earnings of $0.98 Per Share (NYSE:IMAX)

IMAX Co. (NYSE:IMAXFree Report) – Equities research analysts at Wedbush upped their FY2025 earnings per share (EPS) estimates for IMAX in a research report issued to clients and investors on Thursday, July 18th. Wedbush analyst A. Reese now forecasts that the company will post earnings per share of $0.98 for the year, up from their previous estimate of $0.96. Wedbush has a “Outperform” rating and a $22.00 price objective on the stock. The consensus estimate for IMAX’s current full-year earnings is $0.61 per share. Wedbush also issued estimates for IMAX’s FY2026 earnings at $1.29 EPS.

Other analysts have also recently issued research reports about the company. Rosenblatt Securities reaffirmed a “buy” rating and set a $25.00 price target on shares of IMAX in a research report on Monday, June 17th. Barrington Research reiterated an “outperform” rating and issued a $24.00 target price on shares of IMAX in a research report on Monday, April 22nd. B. Riley raised their price target on shares of IMAX from $27.00 to $30.00 and gave the stock a “buy” rating in a research report on Monday, July 8th. Benchmark reaffirmed a “buy” rating and issued a $22.00 price objective on shares of IMAX in a report on Thursday, June 20th. Finally, Roth Mkm increased their price target on IMAX from $22.00 to $23.00 and gave the stock a “buy” rating in a research report on Thursday, July 18th. One investment analyst has rated the stock with a sell rating, two have assigned a hold rating and six have assigned a buy rating to the stock. Based on data from MarketBeat, IMAX currently has a consensus rating of “Moderate Buy” and a consensus price target of $22.00.

Get Our Latest Research Report on IMAX

IMAX Trading Down 0.4 %

NYSE:IMAX opened at $17.75 on Monday. The company has a market capitalization of $934.01 million, a P/E ratio of 36.98, a PEG ratio of 1.47 and a beta of 1.26. IMAX has a 12 month low of $13.20 and a 12 month high of $20.70. The firm has a fifty day simple moving average of $16.63 and a 200-day simple moving average of $16.05.

IMAX (NYSE:IMAXGet Free Report) last released its earnings results on Thursday, April 25th. The company reported $0.08 EPS for the quarter, topping analysts’ consensus estimates of $0.03 by $0.05. IMAX had a net margin of 7.13% and a return on equity of 9.47%. The company had revenue of $79.12 million during the quarter, compared to analysts’ expectations of $77.88 million.

Hedge Funds Weigh In On IMAX

Several hedge funds and other institutional investors have recently made changes to their positions in IMAX. Private Capital Management LLC lifted its holdings in IMAX by 10.0% in the 1st quarter. Private Capital Management LLC now owns 1,304,364 shares of the company’s stock valued at $21,092,000 after purchasing an additional 118,649 shares in the last quarter. Bayesian Capital Management LP boosted its position in IMAX by 84.8% during the first quarter. Bayesian Capital Management LP now owns 22,884 shares of the company’s stock worth $370,000 after acquiring an additional 10,500 shares during the last quarter. Price T Rowe Associates Inc. MD grew its stake in IMAX by 19.7% during the 1st quarter. Price T Rowe Associates Inc. MD now owns 13,082 shares of the company’s stock valued at $212,000 after acquiring an additional 2,153 shares in the last quarter. PEAK6 Investments LLC acquired a new stake in IMAX in the 1st quarter valued at about $210,000. Finally, Keeley Teton Advisors LLC lifted its stake in IMAX by 16.3% in the 1st quarter. Keeley Teton Advisors LLC now owns 58,605 shares of the company’s stock worth $948,000 after purchasing an additional 8,205 shares in the last quarter. Hedge funds and other institutional investors own 93.51% of the company’s stock.

Insider Activity

In other news, EVP Calamera Pablo sold 6,130 shares of IMAX stock in a transaction dated Friday, April 26th. The shares were sold at an average price of $17.05, for a total value of $104,516.50. Following the sale, the executive vice president now owns 42,269 shares in the company, valued at $720,686.45. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Insiders own 24.08% of the company’s stock.

About IMAX

(Get Free Report)

IMAX Corporation, together with its subsidiaries, operates as a technology platform for entertainment and events worldwide. The company operates in two segments, Content Solutions and Technology Products and Services. The company offers IMAX DMR, a proprietary technology that digitally remasters films and other content into IMAX formats for distribution to the IMAX network; IMAX Enhanced that provides end-to-end technology across streaming content and entertainment devices at home; and SSIMWAVE, an AI-driven video quality solutions for media and entertainment companies.

See Also

Earnings History and Estimates for IMAX (NYSE:IMAX)

Receive News & Ratings for IMAX Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for IMAX and related companies with MarketBeat.com's FREE daily email newsletter.